- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AGG-523 (Aggrecanase Inhibitor)
Total 886 results
-
Antengene CorporationRecruitingDiffuse Large B-cell Lymphoma | Indolent Non-Hodgkin LymphomaChina
-
National Cancer Institute (NCI)CompletedPheochromocytoma | ParagangliomaUnited States
-
PfizerWithdrawnDiabetes Mellitus | Diabetic Retinopathy
-
PfizerCompletedThyroid NeoplasmsUnited States, Canada, Czech Republic, Poland, China, Italy, Spain, India, United Kingdom
-
PfizerCompletedAdvanced Solid TumorsUnited States
-
University of Michigan Rogel Cancer CenterCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
PfizerCompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Argentina, Australia, Brazil, Canada, Chile, China, France, Mexico, Netherlands, Spain, United Kingdom, Italy, Hong Kong, Russian Federation
-
AmgenCompletedDiabetes, Hyperlipidemia, Mixed DyslipidemiaUnited States, Canada, France, Korea, Republic of, China, Argentina, Russian Federation, Colombia, Turkey, Brazil
-
PfizerCompletedKidney NeoplasmsKorea, Republic of, United States, Canada, Spain, Italy, United Kingdom, China, Singapore, Slovakia, France, Japan, Australia, Germany, Taiwan, Brazil, Russian Federation, India, Poland, Austria, Greece, Ireland, Sweden
-
PfizerTerminatedMetastatic Renal Cell CarcinomaUnited States, Czechia
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic Solid TumorsAustralia, China
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingMyeloid Malignancy | Relapsed/Refractory Acute Myeloid LeukaemiaChina
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Alvotech Swiss AGIqvia Pty LtdCompletedHealthy Adult SubjectsNew Zealand, United Kingdom
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Kidney Disease | Sickle Cell Disease | Pulmonary HypertensionUnited States
-
AmgenCompletedRectal Cancer | Colon Cancer
-
Tri-Service General HospitalInstitute of Nuclear Energy Research, TaiwanCompleted
-
HutchmedCompleted
-
AmgenCompletedLocally Recurrent and Metastatic Breast Cancer
-
PfizerCompletedKidney NeoplasmsUnited States, China, Malaysia, India, Taiwan, Russian Federation, Mexico, Bosnia and Herzegovina, South Africa, Bulgaria, Chile, Philippines, Romania, Ukraine
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
Arog Pharmaceuticals, Inc.WithdrawnCarcinoma, Non-Small-Cell Lung
-
National Cancer Institute (NCI)WithdrawnAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma
-
Memorial Sloan Kettering Cancer CenterAgios Pharmaceuticals, Inc.RecruitingChondrosarcoma | IDH1 Gene Mutation | Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 3United States
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
University of MinnesotaCompletedDiabetic RetinopathyUnited States
-
Azienda Ospedaliera Universitaria Integrata VeronaCompletedRadius Fracture DistalItaly
-
AllerganCompletedAlopeciaUnited States
-
AmgenCompletedHealthy ParticipantsUnited States
-
Neuroscience Trials AustraliaMacquarie University, Australia; Calvary Health Care Bethlehem; Westmead Hosptial and other collaboratorsCompletedAmyotrophic Lateral SclerosisAustralia
-
AmgenCompletedHypercholesterolemiaUnited States, Denmark, Belgium, Czechia, Austria, Australia, Canada, Hungary, South Africa
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedMalignant Neoplasm of BreastUnited States
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research InstituteActive, not recruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCRecruitingPneumonia | Hematologic Malignancy | Pseudomonas AeruginosaUnited States
-
Aligos TherapeuticsActive, not recruitingHealthy VolunteersUnited States
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, Czechia, Italy, Portugal, Hong Kong, Thailand, Singapore, Bulgaria, Turkey, Argentina, Belgium, G... and more
-
Lynkcell EuropeAvailableKidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
-
Memorial Sloan Kettering Cancer CenterPfizer; National Comprehensive Cancer NetworkCompletedAdenoid Cystic CarcinomaUnited States
-
Agios Pharmaceuticals, Inc.Approved for marketingAcute Myeloid Leukemia | Relapsed Pediatric AML | Relapsed Adult AML
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
Oregon Health and Science UniversityNational Institute of Nursing Research (NINR)Completed
-
Bio-innova Co., LtdNot yet recruiting
-
Bright Future Pharmaceuticals Factory O/B Bright...Chinese University of Hong KongUnknown
-
AmgenCompletedSarcoma | Soft Tissue Sarcoma | Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma
-
M.D. Anderson Cancer CenterAmgenCompletedAdvanced Cancer | Solid TumorsUnited States